UBS AM’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
36,570
-112,254
| -75% | -$778K | ﹤0.01% | 2541 |
|
|
2025
Q1 | $1.3M | Buy |
148,824
+18,859
| +15% | +$165K | ﹤0.01% | 2195 |
|
|
2024
Q4 | $1M | Buy |
129,965
+9,351
| +8% | +$72.2K | ﹤0.01% | 2364 |
|
|
2024
Q3 | $1.2M | Buy |
120,614
+73,965
| +159% | +$733K | ﹤0.01% | 2307 |
|
|
2024
Q2 | $424K | Sell |
46,649
-48,460
| -51% | -$440K | ﹤0.01% | 2659 |
|
|
2024
Q1 | $832K | Hold |
95,109
| – | – | ﹤0.01% | 2100 |
|
|
2023
Q4 | $1.06M | Hold |
95,109
| – | – | ﹤0.01% | 1994 |
|
|
2023
Q3 | $853K | Hold |
95,109
| – | – | ﹤0.01% | 2040 |
|
|
2023
Q2 | $866K | Hold |
95,109
| – | – | ﹤0.01% | 2065 |
|
|
2023
Q1 | $866K | Buy |
95,109
+5,944
| +7% | +$54.2K | ﹤0.01% | 2065 |
|
|
2022
Q4 | $845K | Buy |
89,165
+6,020
| +7% | +$57.1K | ﹤0.01% | 1933 |
|
|
2022
Q3 | $708K | Buy |
83,145
+1,624
| +2% | +$13.8K | ﹤0.01% | 2159 |
|
|
2022
Q2 | $915K | Hold |
81,521
| – | – | ﹤0.01% | 2012 |
|
|
2022
Q1 | $1.33M | Buy |
81,521
+35,660
| +78% | +$582K | ﹤0.01% | 1993 |
|
|
2021
Q4 | $814K | Buy |
45,861
+7,491
| +20% | +$133K | ﹤0.01% | 2316 |
|
|
2021
Q3 | $564K | Sell |
38,370
-25,635
| -40% | -$377K | ﹤0.01% | 2454 |
|
|
2021
Q2 | $945K | Buy |
64,005
+4,205
| +7% | +$62.1K | ﹤0.01% | 2240 |
|
|
2021
Q1 | $784K | Hold |
59,800
| – | – | ﹤0.01% | 2195 |
|
|
2020
Q4 | $781K | Hold |
59,800
| – | – | ﹤0.01% | 2103 |
|
|
2020
Q3 | $807K | Buy |
59,800
+21,761
| +57% | +$294K | ﹤0.01% | 1928 |
|
|
2020
Q2 | $431K | Buy |
38,039
+800
| +2% | +$9.06K | ﹤0.01% | 2177 |
|
|
2020
Q1 | $377K | Buy |
37,239
+16,439
| +79% | +$166K | ﹤0.01% | 2083 |
|
|
2019
Q4 | $275K | Buy |
+20,800
| New | +$275K | ﹤0.01% | 2387 |
|